We report four HCV–HIV-coinfected patients who developed herpes zoster or muco-cutaneous herpes virus disease shortly after starting interferon-free antiviral treatment for HCV. We suggest that in our patients the prompt clearance of HCV following direct-acting antivirals leads to a paradoxical effect on the innate and adaptive immune system mediating the reactivation of herpetic infection.
References
1.
Del BelloD., NagyF.I., HanaJ.Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients.Curr Opin HIV AIDS2015; 10: 337–347.
2.
FeuthT., ArendsJ.E., FransenJ.H.Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.PLoS ONE2013; 8: e59302.
3.
DomingoP., TorresO.H., RisJ., VazquezG.Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection.Am J Med2001; 110: 605–609.
4.
DunićI., Djurkovic-DjakovicO., VesicS., ZerjavS., JevtovicD.Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors.Int J STD AIDS2005; 16: 475–478.
5.
RosenH.R.Emerging concepts in immunity to hepatitis C virus infection.J Clin Invest2013; 123: 4121–4130.
6.
MárquezM., Romero-CoresP., Montes-OcaM.Immune activation response in chronic HIV-infected patients: influence of hepatitis C virus coinfection.PLoS ONE2015; 10: e0119568.
7.
MartínezE., GatellJ., Mora'nY.High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.Clin Infect Dis1998; 27: 1510–1513.
BurchillM.A., Golden-MasonL., Wind-RotoloM., RosenH.R.Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.J Viral Hepat2015; 22: 983–991.
10.
SertiE., Chepa-LotreaX., KimY.J.Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function.Gastroenterology2015; 149: 190–200.
11.
SpaanM., van OordG., KreefftK.Immunological analysis during interferon-free therapy for chronic hepatitis C virus infection reveals modulation of the natural killer cell compartment.J Infect Dis2016; 213: 216–223.
12.
PerellóC.S., Fernández-CarrilloC., LondoñoM.C.Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents.Clin Gastroenterol Hepatol2016; doi: 10.1016/j.cgh.2016.05.016.
13.
OlivieroB., MeleD., DegasperiE.Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection.J Hepatol2013; 59: 38–44.
De MonteA., CourjonJ., AntyR.Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge.J Clin Virol2016; 78: 27–30.
16.
CollinsJ.M., RaphaelK.L., TerryC.Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir.Clin Infect Dis2015; 61: 1304–1306.
17.
TakayamaH., SatoT., IkedaF., FujikiS.Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection.Hepatol Res2016; 46: 489–491.
18.
WangC., JiD., ChenJ.Hepatitis due to reactivation of HBV in endemic areas among patients with hepatitis C treated with direct-acting antivirals agents.Clin Gastroenterol Hepatol2016; doi:10.1016/j.cgh.2016.06.023.
